Source-backed questions to discuss with your provider when considering Xeomin or Daxxify for wrinkle reduction, with guidance on formulation differences, safety considerations, and international care coordination.
Last reviewed: 2026-05-06
11 min read
Ready to explore your options in Istanbul?
Connect with our coordination team for a personalised treatment plan, verified provider matching, and travel logistics support.
Content is educational and planning-oriented. It does not replace diagnosis, treatment, or personalized medical advice from a licensed healthcare professional. Outcomes vary by individual case.
Xeomin is a 'naked' neurotoxin without accessory proteins, while Daxxify uses a proprietary peptide (RTP004) designed to extend duration.
Both products are FDA-approved, but they differ in formulation, storage requirements, and typical treatment intervals.
Your provider should be able to explain their experience with each product and help you determine which may suit your goals.
International patients should maintain detailed treatment records for ongoing care coordination across borders.
Educational information only
This content is general education and does not replace evaluation by a licensed clinician. If you have symptoms, complications, or urgent concerns, seek in-person medical care.
Understanding Xeomin and Daxxify as Treatment Options
Xeomin (incobotulinumtoxinA) and Daxxify (daxibotulinumtoxinA) are both FDA-approved botulinum toxin type A products used for wrinkle reduction, but they differ in their formulation approaches. Understanding these differences can help you have a more informed conversation with your provider about which option may be appropriate for your situation.
Xeomin is often referred to as the "naked" neurotoxin because it contains only the purified 150-kDa core neurotoxin without accessory proteins or human serum albumin (HSA) S1. This formulation means it can be stored at room temperature before reconstitution and may appeal to patients concerned about protein exposure or those who have experienced diminishing response to other neurotoxins over time.
Daxxify received FDA approval for glabellar lines in 2022 and expanded to cervical dystonia in 2024 S2. Its distinguishing feature is the RTP004 peptide, a proprietary stabilizing agent that replaces the human serum albumin found in other products. This peptide carries a positive charge that enhances binding to nerve terminals, which clinical trials suggest may extend the duration of effect.
Both products work by temporarily blocking nerve signals to muscles, reducing the appearance of dynamic wrinkles. The choice between them depends on factors including your treatment goals, prior response to neurotoxins, and practical considerations like treatment scheduling.
Treatment Context
These products are part of the broader injectables and botulinum toxin hub category. Your provider can help you understand how Xeomin or Daxxify compares to other available options based on your specific anatomy and goals.
What Makes These Products Different
The formulations of Xeomin and Daxxify reflect different approaches to stabilizing and delivering botulinum toxin. These differences can affect storage, treatment intervals, and individual response.
Formulation and Storage
Xeomin's protein-free formulation means it can be stored at room temperature unreconstituted, which may simplify inventory management for some practices S1. Once reconstituted with saline, the product is stable for approximately 36 hours under proper conditions.
Daxxify's peptide-based formulation replaces human-derived proteins, which may be relevant for patients with specific concerns about animal-derived products S2. The reconstituted product is stable for approximately 72 hours, offering more flexibility than some alternatives.
Duration of Effect
Clinical trials suggest these products may have different typical durations. Xeomin's effects typically last 3-4 months, with a recommended re-treatment interval of at least 12 weeks S1. Daxxify's trials have shown a median duration of approximately 6 months for some patients, which could reduce the frequency of treatments needed S2.
Individual Variation
Duration can vary significantly between individuals based on injection technique, dose, muscle strength, metabolism, and prior exposure to neurotoxins. Your results may differ from clinical trial averages.
Feature
Xeomin
Daxxify
Active Ingredient
IncobotulinumtoxinA (150-kDa core only)
DaxibotulinumtoxinA with RTP004 peptide
Stabilizing Agent
None (protein-free)
RTP004 peptide
Storage (unreconstituted)
Room temperature
Refrigerated (2-8°C)
Reconstituted Stability
~36 hours
~72 hours
Typical Duration
3-4 months
Up to 6 months median
FDA Approvals
Glabellar lines, cervical dystonia, blepharospasm
Glabellar lines, cervical dystonia
Unit Dosing Considerations
Each neurotoxin product has its own unit system that is not interchangeable with others. A provider must understand the specific dosing requirements for each product when treating different areas S3. The number of units needed can vary based on the treatment area, muscle strength, and desired outcome. Never assume that units from one product directly translate to another.
Key Questions to Ask Your Provider
Having a structured conversation with your provider can help you make a more informed decision about whether Xeomin, Daxxify, or another option is appropriate for your treatment goals.
About Provider Experience
Provider Verification
Choosing an experienced injector is essential for safe, effective treatment. The provider verification process should include confirming credentials, reviewing before-and-after photos, and discussing their specific experience with each product you're considering.
When evaluating a provider's experience, consider asking:
How long have you been administering botulinum toxin injections, and how frequently do you perform these treatments? Experience matters, but so does currency—providers who regularly perform injections are likely to have refined their technique.
What is your experience with both Xeomin and Daxxify specifically? If you're considering one of these products, confirm your provider has substantial hands-on experience with it, not just general neurotoxin training.
Can you show me before-and-after photos of patients you have treated with these products? This can help you assess the provider's aesthetic approach and whether it aligns with your goals.
How do you determine the appropriate dose for each patient? Dose selection should be individualized based on your anatomy, muscle strength, and desired outcome—not a one-size-fits-all approach.
What is your policy if I'm not satisfied with the results? Understanding follow-up options and potential adjustments is important for managing expectations.
About Treatment Selection
Based on my goals and anatomy, which product would you recommend, and why? Your provider should be able to explain their reasoning in terms you understand, not just give a blanket recommendation.
How do you handle patients who have previously responded to other neurotoxins? If you've had treatment before, your provider should understand how prior response may inform product selection.
What results can I realistically expect, and when will I see them? Effects typically become apparent within a few days to two weeks, with full results visible by the two-week mark S4.
How should I prepare for my appointment? Your provider should give you specific pre-treatment instructions, including which medications or supplements to avoid.
Red Flags
Be cautious of providers who: guarantee specific outcomes, offer significantly discounted pricing below market rates, skip consultation, or pressure you to decide immediately without time to consider.
Facility Standards
Ensure your provider operates in an appropriate clinical setting. The facility standards for injectable treatments include proper infection control, emergency protocols, and appropriate equipment for managing any adverse events.
Safety Profile and What to Expect
Understanding the safety profile of botulinum toxin products helps you make an informed decision and recognize what is normal versus what may require medical attention.
Common Side Effects
Like all injections, botulinum toxin treatments can cause side effects. Common side effects at the injection site include temporary redness, swelling, bruising, or mild pain S5. These typically resolve within a few days to a week.
Less commonly, patients may experience headache, drooping of the eyelid or eyebrow (ptosis), or asymmetry as the product takes effect S3. These effects are usually temporary but can persist for the duration of the product's action.
Timeline Expectations
Initial effects typically appear within 3-5 days, with full results visible at 10-14 days. If asymmetry occurs, it may become apparent during this window and should be discussed with your provider.
Who Should Avoid These Treatments
Certain conditions contraindicate botulinum toxin treatment or require additional precautions S4, S5:
Allergy to any botulinum toxin product or its components
Infection at the proposed injection site
Certain neurological conditions affecting muscle or nerve function
Pregnancy or breastfeeding (effects are not established)
You should provide a complete medication list to your provider, as certain medications may interact with botulinum toxin or affect bleeding risk S4. This includes blood thinners, muscle relaxants, and some antibiotics.
Understanding Warnings
All botulinum toxin products carry a FDA black box warning about the spread of toxin effects beyond the injection site S3, S5. While rare, this can potentially cause serious effects including difficulty swallowing or breathing, which may be life-threatening. These risks are generally associated with higher doses or inappropriate injection techniques.
Seek Medical Attention
If you experience difficulty swallowing, speaking, or breathing after treatment, seek immediate medical care. These symptoms require prompt evaluation.
Preparing for Your Treatment
Proper preparation can help minimize side effects and optimize your results.
Before Your Appointment
Your provider may advise avoiding alcohol, blood-thinning medications, and certain supplements for several days before treatment to reduce bruising risk S3, S4. Discuss your complete medication and supplement list with your provider well in advance.
Avoid scheduling important events within two weeks of treatment, as initial effects and any adjustments needed typically become apparent during this period S4.
Follow your provider's specific aftercare instructions, as they may have additional recommendations based on your treatment.
Documentation
Request written documentation of your treatment, including the product used, dosage, injection sites, and date. This information is valuable for future treatments and coordinating care with other providers.
Coordinating Care Across Borders
International patients face unique considerations when seeking botulinum toxin treatments away from their home country.
Documentation to Maintain
Keep a detailed record of each treatment, including S4:
Product name and manufacturer
Dosage and units used
Injection sites (specific areas treated)
Date of treatment
Provider name and contact information
Any adverse effects or observations
This documentation helps any future provider understand your treatment history and plan appropriate care.
Product Availability and Follow-Up
Different products may have varying availability in different countries. If you're considering Daxxify, confirm that it is available and approved in your home country for ongoing maintenance treatments S4. If Daxxify is not available locally, you may need to plan for regular international travel for maintenance or consider an alternative product.
Travel Coordination
Our travel coordination services can help international patients plan treatment timing, arrange accommodations, and coordinate follow-up care across borders.
Timing Considerations
Because effects can take two weeks to fully manifest, schedule your initial treatment with adequate time before any important events or your departure from the area. If you're traveling internationally for treatment, plan to stay for at least 10-14 days in case adjustments are needed.
For ongoing care, work with your provider to establish an appropriate treatment schedule that accounts for travel logistics while maintaining consistent care.
Making Your Decision
Choosing between Xeomin and Daxxify—or deciding which questions to prioritize with your provider—is a personal decision based on your goals, priorities, and circumstances.
Consider what matters most to you: Daxxify's potentially longer duration may reduce treatment frequency, which could be valuable if you're coordinating care internationally. Xeomin's protein-free formulation may appeal if you have concerns about additive ingredients or have experienced reduced response to other products over time.
Your provider's experience and your comfort level with them are equally important factors. A provider who takes time to answer your questions, explains their reasoning, and helps you understand realistic expectations is likely to provide better care than one who rushes consultations or makes sweeping promises.
Next Steps
The treatment overview can help you understand where these products fit in the broader context of injectable options. Discuss your goals and concerns openly with your provider to determine the most appropriate approach for your individual situation.
Ultimately, the best decision is one made with adequate information, realistic expectations, and a provider you trust to guide you through the process safely.
1.Jost et al.. “Clinical and pharmacological properties of incobotulinumtoxinA and its use in neurological disorders.” Drug Design, Development and Therapy. 2015. Accessed 2026-02-20.https://pmc.ncbi.nlm.nih.gov/articles/PMC4389813/
